Delivery Order SPE2DB25D3017-SPE2DB25FVHYV

Award Date 5/2/25
Potential Completion Date 5/23/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venclexta 100 mg tablets. The contract has a ceiling value of $8,880.15 and runs through January 30, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The contract is a firm fixed-price delivery order issued under a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Venclexta 100 mg tablets, a prescription medication. The contract has a ceiling value of $9,728.17 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 firm fixed-price contract is for the delivery of 4,567,503,935 units of the drug Venclexta 100 mg tablets. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Venclexta 100 mg tablets. The contract has a ceiling value of $4,443.68 and is a firm fixed-price arrangement. The ultimate completion date is November 5, 2024. This award is not associated with any set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for...
This is a $9,728.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venclexta 100 mg tablets. The award is not associated with a set-aside program. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $9,728.17, is for the delivery of Venclexta 100 mg tablets. This is a firm fixed-price delivery order contract with a performance period through May 2, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This is a $17,760.30 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Venclexta 100 mg tablets to support military treatment programs and facilities. The delivery order has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $29,184.51, is for the delivery of Venclexta 100 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Venclexta 100 mg tablet, with a ceiling value of $9,728.17 and a completion date of January 30, 2025. This contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venclexta 100 mg tablets. The contract has a firm fixed-price pricing structure and a total ceiling value of $35,520.60. It was awarded on September 5, 2024, with an ultimate completion date of September 26, 2024. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
  • SPE2DB25D3017
    Indefinite Delivery Contract
  • SPE2DB25D3017-SPE2DB25FVHYV
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venclexta 100 mg tablets. The contract has a ceiling value of $9,728.17 and a period of performance through May 23, 2025. This order is not set aside and is a firm fixed-price, delivery order contract. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and government healthcare programs through December 2026.

Generated 8/3/25, 12:53 AM